Press Releases for the Psychedelics Industry | Page 4 of 37

Psychedelics News

Press Releases

19 Jan 2022

Enveric Biosciences CEO, Dr. Joseph Tucker, Provides 2021 Year in Review and 2022 Outlook in Letter to Shareholders

Enveric launched as a patient-centric biotechnology company, employing innovation and scientific leadership as core principles....

By Microdose

Press Releases

6 Jan 2022

MHRA Guidance for Regulatory Decision-Making Supports Albert Labs’ Licensing Pathway

MHRA Guidance on the use of Real-World Data in Clinical Studies for Regulatory Decision-Making Supports Albert Labs' Licensing Pathway NEWS PROVIDED BY Albert Labs Inc....

By Microdose

Press Releases

17 Dec 2021

BLACKHAWK GROWTH ANNOUNCES PLAN TO SPIN-OUT PSYCHEDELIC SUBSIDIARIES AND PROPOSES 1:1 DISTRIBUTION RATIO

The company will undertake a spin-out transaction whereby the shares of its wholly owned subsidiaries MindBio Therapeutics Pty....

By Microdose

Press Releases

21 Sep 2021

Eversio Wellness harvests its first legally grown psychoactive mushrooms

Eversio Wellness, a mushroom wellness company, has harvested its first legal flush of psilocybin-producing mushrooms under its Health Canada-issued Controlled Substances Dealer’s Licence....

By Microdose

Join Our Newsletter for Exclusive Updates, Stories, and More

Press Releases

4 Aug 2021

The Conscious Fund and Departures Capital launch a Partnership to increase awareness for Public Companies within the Psychedelic Medicine Sector

The Conscious Fund and Departures Capital launch a Partnership to increase awareness for Public Companies within the Psychedelic Medicine Sector...

By Microdose

Press Releases

17 Jul 2021

The Newly Institute Announces the Execution of a Joint Working Agreement with Drug Science for the Drug Science Medical Psychedelics Working Group

The Drug Science Medical Psychedelics Working Group is a consortium of Drug Science experts, industry partners, patient representatives and policymakers...

By Microdose

Press Releases

13 Jul 2021

Nextage Therapeutics and Subsidiary IMIO Life Announce Positive Pre- Clinical Toxicity Results for Proprietary Brain Targeting Drug Delivery System

Nextage Therapeutics & IMIO Life Announce Positive Pre-Clinical Toxicity Results for Proprietary Brain Targeting Drug Delivery System...

By Microdose

Press Releases

7 Jul 2021

Amanda Galbraith, Principal at Navigator Joins the Board of Psyched Wellness

Toronto, Ontario--(Newsfile Corp....

By Microdose

Press Releases

30 Jun 2021

Psyched Wellness Announces Matthew Singh Joins Team as CPG and Branding Consultant

Toronto, Ontario–(Newsfile Corp....

By Microdose

Follow us on social

Latest News

Trump’s Psychedelic Fast-Track Order Changes the Timeline. It Also Redraws the Competitive Map.

AbbVie Withdraws Patent Challenge, Clearing Path for Enveric’s Psychedelic IP Strategy

Breaking: Enveric Reports New Mechanistic Data Supporting Non-Hallucinogenic Neuroplastogen Strategy

Professional Training in Psychedelic Medicine

Psychedelic medicine is reshaping the future of mental health care. From the power of microdosing LSD to the promise of MDMA in PTSD, the world of medical psychedelics offers transformative possibilities. Our comprehensive, CE-accredited course provides you with the knowledge and understanding you need to tap into this groundbreaking field.

WordPress Ads

No Result

View All Result